CLPT
Price
$14.11
Change
-$0.14 (-0.98%)
Updated
May 9 closing price
Capitalization
183.44M
One day until earnings call
DCTH
Price
$14.84
Change
+$0.49 (+3.41%)
Updated
May 9 closing price
Capitalization
109.8M
92 days until earnings call
Ad is loading...

CLPT vs DCTH

Header iconCLPT vs DCTH Comparison
Open Charts CLPT vs DCTHBanner chart's image
ClearPoint Neuro
Price$14.11
Change-$0.14 (-0.98%)
Volume$199.6K
Capitalization183.44M
Delcath Systems
Price$14.84
Change+$0.49 (+3.41%)
Volume$940.93K
Capitalization109.8M
CLPT vs DCTH Comparison Chart
Loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DCTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPT vs. DCTH commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPT is a Hold and DCTH is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (CLPT: $14.11 vs. DCTH: $14.84)
Brand notoriety: CLPT and DCTH are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPT: 82% vs. DCTH: 196%
Market capitalization -- CLPT: $183.44M vs. DCTH: $109.8M
CLPT [@Medical Specialties] is valued at $183.44M. DCTH’s [@Medical Specialties] market capitalization is $109.8M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPT’s FA Score shows that 0 FA rating(s) are green whileDCTH’s FA Score has 1 green FA rating(s).

  • CLPT’s FA Score: 0 green, 5 red.
  • DCTH’s FA Score: 1 green, 4 red.
According to our system of comparison, DCTH is a better buy in the long-term than CLPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPT’s TA Score shows that 7 TA indicator(s) are bullish while DCTH’s TA Score has 6 bullish TA indicator(s).

  • CLPT’s TA Score: 7 bullish, 4 bearish.
  • DCTH’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both CLPT and DCTH are a good buy in the short-term.

Price Growth

CLPT (@Medical Specialties) experienced а -2.22% price change this week, while DCTH (@Medical Specialties) price change was +19.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

CLPT is expected to report earnings on Aug 12, 2025.

DCTH is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPT($183M) has a higher market cap than DCTH($110M). DCTH YTD gains are higher at: 23.256 vs. CLPT (-8.257). CLPT has higher annual earnings (EBITDA): -20.99M vs. DCTH (-46.11M). DCTH has more cash in the bank: 32.5M vs. CLPT (23.1M). DCTH has less debt than CLPT: DCTH (10.2M) vs CLPT (13.9M). CLPT has higher revenues than DCTH: CLPT (24M) vs DCTH (2.07M).
CLPTDCTHCLPT / DCTH
Capitalization183M110M166%
EBITDA-20.99M-46.11M46%
Gain YTD-8.25723.256-36%
P/E RatioN/A212.77-
Revenue24M2.07M1,162%
Total Cash23.1M32.5M71%
Total Debt13.9M10.2M136%
FUNDAMENTALS RATINGS
CLPT vs DCTH: Fundamental Ratings
CLPT
DCTH
OUTLOOK RATING
1..100
3138
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
6588
SMR RATING
1..100
9493
PRICE GROWTH RATING
1..100
3936
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/a28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPT's Valuation (53) in the null industry is somewhat better than the same rating for DCTH (90) in the Medical Specialties industry. This means that CLPT’s stock grew somewhat faster than DCTH’s over the last 12 months.

CLPT's Profit vs Risk Rating (65) in the null industry is in the same range as DCTH (88) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to DCTH’s over the last 12 months.

DCTH's SMR Rating (93) in the Medical Specialties industry is in the same range as CLPT (94) in the null industry. This means that DCTH’s stock grew similarly to CLPT’s over the last 12 months.

DCTH's Price Growth Rating (36) in the Medical Specialties industry is in the same range as CLPT (39) in the null industry. This means that DCTH’s stock grew similarly to CLPT’s over the last 12 months.

DCTH's P/E Growth Rating (1) in the Medical Specialties industry is significantly better than the same rating for CLPT (100) in the null industry. This means that DCTH’s stock grew significantly faster than CLPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPTDCTH
RSI
ODDS (%)
Bullish Trend 3 days ago
54%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DCTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UURAF1.130.02
+1.80%
Ucore Rare Metals, Inc.
CMWAY107.901.43
+1.34%
Commonwealth Bank of Australia
SSREY45.340.22
+0.49%
Swiss Re Ltd
SRUUF15.68-0.13
-0.82%
Sprott Physical Uranium Trust
GNMSF193.13-3.09
-1.58%
Genmab A/S

DCTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DCTH has been loosely correlated with ALC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DCTH jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DCTH
1D Price
Change %
DCTH100%
+3.38%
ALC - DCTH
39%
Loosely correlated
-0.14%
QDEL - DCTH
38%
Loosely correlated
-0.33%
DHR - DCTH
35%
Loosely correlated
-2.61%
MMSI - DCTH
35%
Loosely correlated
-0.27%
CLPT - DCTH
35%
Loosely correlated
-0.98%
More